Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

11 Nov 2025 07:00

RNS Number : 9353G
4imprint Group PLC
11 November 2025
 

 

 

11 November 2025

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a resilient operational and financial performance against the backdrop of volatile macroeconomic conditions in the 10-month period up to the end of October 2025.

 

The Board expects full year Group revenue of not less than $1.32bn, which is at the high end of the current analyst forecast range, and profit before tax of not less than $142m, which is above the upper end of the current analyst forecast range.

 

Group revenue for the first 10 months of 2025 was 2% below the same period in 2024. Order intake has continued to run approximately 3% below prior year with average order values in line with prior year, as the business has traded resiliently through its peak seasonal months. Existing customer order count was flat year to date, reflecting strong and consistent retention rates. New customer order count was down 13% year to date, a continuation of the performance seen in the first half.

 

Gross profit margin has remained strong at just below 33%, as product cost increases due to tariffs are being phased in later than anticipated, while the marketing mix is providing the flexibility we anticipated. As a result, a double-digit operating profit margin has been maintained in the 10-month period.

 

The Group remains highly cash generative and well financed, with a cash balance of $124m at the end of October 2025. The Board has approved a c.$10m capital expenditure for the relocation of its leased downtown Oshkosh, Wisconsin office space to its recently expanded distribution centre which is expected to be completed in mid-2026.

 

The Board is confident that the Group will continue to effectively navigate market conditions, delivering solid financial results while positioning the business to take advantage of opportunities that will present themselves as economic and market conditions improve.

 

For further information, please contact:

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

 

MHP Group

Tel. + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Michelle Brukwicki, Chief Financial Officer

Katie Hunt

Eleni Menikou

Steve Bindas, Director of Investor Relations

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQBLFFEFLZFBK
Date   Source Headline
7th Aug 20247:00 amRNSHalf-year Report
17th Jun 202411:51 amRNSHolding(s) in Company
29th May 20249:27 amRNSEBT Purchase
22nd May 20243:25 pmRNSResult of AGM
22nd May 20247:00 amRNSCFO Succession
22nd May 20247:00 amRNSAGM Statement
16th May 20249:25 amRNSHolding(s) in Company
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.